Shares in Brighthouse Financial closed down 5% Monday, ending the day at its lowest price since private asset manager Aquarian announced plans in November to buy it. Today's stock drop came after Delaware's insurance regulator said it was calling in outside experts to help review the deal. Brighthouse's stock price shot up last year after Aquarian's Nov. 6 plan to buy the insurance company for $70 a share.

Brighthouse Financial misses Q2 earnings estimates despite higher year-over-year profit, as lower investment income and weaker annuity sales offset underwriting gains.

Brighthouse Financial (BHF) is back in focus after reporting second quarter 2026 results and updating investors on its pending merger with Aquarian Capital, a transaction valued at about US$4.1b. See our latest analysis for Brighthouse Financial. Brighthouse Financial’s share price has softened recently, with a 1 month share price return of down 4.9% and a year to date share price return of down 3.7%. This comes even though the 1 year total shareholder return is 39.7%, which points to earlier...

The headline numbers for Brighthouse Financial (BHF) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Brighthouse Financial (BHF) delivered earnings and revenue surprises of -10.64% and -8.14%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Brighthouse Financial (BHF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Voya Financial's Retirement and Investment Management businesses, strategic acquisitions and capital returns support growth, though higher leverage and competition remain risks.

David Einhorn built his fortune betting against the crowd, and his latest 13F reveals five positions in corners of the market most investors refuse to touch. One signed acquisition is trading at a suspicious discount, and the rest carry catalysts Wall Street keeps ignoring.